<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04799938</url>
  </required_header>
  <id_info>
    <org_study_id>ACTİVE GD-15</org_study_id>
    <nct_id>NCT04799938</nct_id>
  </id_info>
  <brief_title>Effect of Exercise on GDF-15 Levels in Prediabetic Patients</brief_title>
  <official_title>Effect of Exercise on GDF-15 Levels in Prediabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate whether there is a change in GDF-15 levels in&#xD;
      individuals with prediabetes at the 2nd hour after the first exercise and after a 12-week&#xD;
      exercise program with guide-based exercise programs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      GDF-15, which has anorexigenic effects, increases with exercise. In prediabetic patients,&#xD;
      GDF-15 is higher than healthy controls. The effect of exercise on GDF-15 levels in&#xD;
      prediabetic patients is unknown.&#xD;
&#xD;
      The aim of this study is to evaluate whether there is a change in GDF-15 levels after the&#xD;
      application of guideline-based exercise programs in individuals with prediabetes at the 2nd&#xD;
      hour after the first exercise and after a 12-week exercise program.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Exercise intervention will be applied to intervention group All participiants will be applied to standard recommendations</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of Growth Diferantiation Factor-15</measure>
    <time_frame>12 weeks</time_frame>
    <description>Level of Growth Diferantiation Factor-15</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of VO2max</measure>
    <time_frame>12 weeks</time_frame>
    <description>Level of VO2max</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>PreDiabetes</condition>
  <arm_group>
    <arm_group_label>İntevention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Prediabetic patients with age 30-50 and overweight Standart recommendations Exercise intervention will be made.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Prediabetic patients with age 30-50 and overweight Only Standart recommendations</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Metformin Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Prediabetic patients who received metformin Standart recommendations</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>180 minutes of moderate-intensity exercise per week</description>
    <arm_group_label>İntevention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Body mass index 30-34.9 kg / m2&#xD;
&#xD;
          -  Sedentary life-style (Physical activity below 300 kcal / day will be assessed by&#xD;
             Minnesota Leisure Physical Activity Questionnaire)&#xD;
&#xD;
          -  Those who have sufficient motivation to participate in the exercise program (will be&#xD;
             evaluated by face-to-face interview by the researchers)&#xD;
&#xD;
          -  Having the same weight for 6 months before participating in the study (± 2.5 kg)&#xD;
&#xD;
          -  Those diagnosed with prediabetes by oral glucose tolerance test and / or HbA1c&#xD;
             measurement will be included.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Serious medical condition (e.g. advanced malignancy or major neurological, psychiatric&#xD;
             or endocrine disease, respiratory failure, etc.)&#xD;
&#xD;
          -  Having cardiovascular disease&#xD;
&#xD;
          -  Having diabetes&#xD;
&#xD;
          -  Using metformin&#xD;
&#xD;
          -  Taking hormone replacement therapy&#xD;
&#xD;
          -  less than 1 year life expectancy&#xD;
&#xD;
          -  HIV positivity&#xD;
&#xD;
          -  Substance use&#xD;
&#xD;
          -  Functional dependence&#xD;
&#xD;
          -  Cognitive weakness&#xD;
&#xD;
          -  Those with other diseases that will affect the study result (respiratory diseases,&#xD;
             muscle diseases, etc.)&#xD;
&#xD;
          -  Those who use drugs or supplements that will affect the results of the study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elif Yıldırım Ayaz, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sultan Abdülhamid Han Training and Rsearch Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elif Yıldırım Ayaz, M.D.</last_name>
    <phone>+905325148300</phone>
    <email>drelifyildirim@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sultan Abdülhamid Han Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elif Yıldırım Ayaz, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 7, 2021</study_first_submitted>
  <study_first_submitted_qc>March 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2021</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</investigator_affiliation>
    <investigator_full_name>Elif Yıldırım Ayaz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>GDF-15</keyword>
  <keyword>Physical Exercise</keyword>
  <keyword>Prediabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

